DNA Diagnostics for Schistosomiasis Control
Despite extensive efforts over the last few decades, the global disease burden of schistosomiasis still remains unacceptably high. This could partly be attributed to the lack of accurate diagnostic tools for detecting human and animal schistosome infections in endemic areas. In low transmission and...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-08-01
|
Series: | Tropical Medicine and Infectious Disease |
Subjects: | |
Online Access: | http://www.mdpi.com/2414-6366/3/3/81 |
id |
doaj-c7c6417af7664e4d88b7a765f26059a5 |
---|---|
record_format |
Article |
spelling |
doaj-c7c6417af7664e4d88b7a765f26059a52020-11-25T01:41:02ZengMDPI AGTropical Medicine and Infectious Disease2414-63662018-08-01338110.3390/tropicalmed3030081tropicalmed3030081DNA Diagnostics for Schistosomiasis ControlKosala G. Weerakoon0Catherine A. Gordon1Donald P. McManus2Molecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaMolecular Parasitology Laboratory, Infectious Diseases Division, QIMR Berghofer Medical Research Institute, Brisbane 4006, AustraliaDespite extensive efforts over the last few decades, the global disease burden of schistosomiasis still remains unacceptably high. This could partly be attributed to the lack of accurate diagnostic tools for detecting human and animal schistosome infections in endemic areas. In low transmission and low prevalence areas where schistosomiasis elimination is targeted, case detection requires a test that is highly sensitive. Diagnostic tests with low sensitivity will miss individuals with low infection intensity and these will continue to contribute to transmission, thereby interfering with the efficacy of the control measures operating. Of the many diagnostic approaches undertaken to date, the detection of schistosome DNA using DNA amplification techniques including polymerase chain reaction (PCR) provide valuable adjuncts to more conventional microscopic and serological methods, due their accuracy, high sensitivity, and the capacity to detect early pre-patent infections. Furthermore, DNA-based methods represent important screening tools, particularly in those endemic areas with ongoing control where infection prevalence and intensity have been reduced to very low levels. Here we review the role of DNA diagnostics in the path towards the control and elimination of schistosomiasis.http://www.mdpi.com/2414-6366/3/3/81schistosomiasisdiagnosiscontrol and eliminationDNApolymerase chain reaction |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kosala G. Weerakoon Catherine A. Gordon Donald P. McManus |
spellingShingle |
Kosala G. Weerakoon Catherine A. Gordon Donald P. McManus DNA Diagnostics for Schistosomiasis Control Tropical Medicine and Infectious Disease schistosomiasis diagnosis control and elimination DNA polymerase chain reaction |
author_facet |
Kosala G. Weerakoon Catherine A. Gordon Donald P. McManus |
author_sort |
Kosala G. Weerakoon |
title |
DNA Diagnostics for Schistosomiasis Control |
title_short |
DNA Diagnostics for Schistosomiasis Control |
title_full |
DNA Diagnostics for Schistosomiasis Control |
title_fullStr |
DNA Diagnostics for Schistosomiasis Control |
title_full_unstemmed |
DNA Diagnostics for Schistosomiasis Control |
title_sort |
dna diagnostics for schistosomiasis control |
publisher |
MDPI AG |
series |
Tropical Medicine and Infectious Disease |
issn |
2414-6366 |
publishDate |
2018-08-01 |
description |
Despite extensive efforts over the last few decades, the global disease burden of schistosomiasis still remains unacceptably high. This could partly be attributed to the lack of accurate diagnostic tools for detecting human and animal schistosome infections in endemic areas. In low transmission and low prevalence areas where schistosomiasis elimination is targeted, case detection requires a test that is highly sensitive. Diagnostic tests with low sensitivity will miss individuals with low infection intensity and these will continue to contribute to transmission, thereby interfering with the efficacy of the control measures operating. Of the many diagnostic approaches undertaken to date, the detection of schistosome DNA using DNA amplification techniques including polymerase chain reaction (PCR) provide valuable adjuncts to more conventional microscopic and serological methods, due their accuracy, high sensitivity, and the capacity to detect early pre-patent infections. Furthermore, DNA-based methods represent important screening tools, particularly in those endemic areas with ongoing control where infection prevalence and intensity have been reduced to very low levels. Here we review the role of DNA diagnostics in the path towards the control and elimination of schistosomiasis. |
topic |
schistosomiasis diagnosis control and elimination DNA polymerase chain reaction |
url |
http://www.mdpi.com/2414-6366/3/3/81 |
work_keys_str_mv |
AT kosalagweerakoon dnadiagnosticsforschistosomiasiscontrol AT catherineagordon dnadiagnosticsforschistosomiasiscontrol AT donaldpmcmanus dnadiagnosticsforschistosomiasiscontrol |
_version_ |
1725042910411358208 |